Home › Free Stock Grades › INDV
Indivior Pharmaceuticals Inc (INDV) Stock Grade
INDV · Healthcare
A+
Market Cap
$4.5B
P/E Ratio
21.4
Revenue Growth (YoY)
+4.3%
Net Margin
17.0%
Return on Equity
—
Dividend Yield
None
About Indivior Pharmaceuticals Inc's fundamentals
Indivior Pharmaceuticals is a specialty pharmaceutical company with a market capitalization of $4.5 billion, currently trading at a P/E ratio of 21.4. The company generated 4.3% year-over-year revenue growth and maintains a net profit margin of 17.0%, indicating healthy profitability relative to sales. The company does not currently pay a dividend, suggesting it may be reinvesting earnings into operations or research and development.